These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12819424)
1. A well-differentiated hepatocellular carcinoma detected only by F-18 FDG positron emission tomography. Krug B; Martinet JP; Lacrosse M; Delos M; Vander Borght T Clin Nucl Med; 2003 Jul; 28(7):606-7. PubMed ID: 12819424 [No Abstract] [Full Text] [Related]
2. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351 [TBL] [Abstract][Full Text] [Related]
10. FDG PET/CT Imaging of sarcomatoid hepatocellular carcinoma: A case report. Chen Z; Wang H; Yu X Asian J Surg; 2024 Aug; 47(8):3708-3709. PubMed ID: 38664188 [No Abstract] [Full Text] [Related]
11. Limited value of 18F-2-deoxyglucose positron emission tomography to detect hepatocellular carcinoma in hepatitis B virus carriers. Jeng LB; Changlai SP; Shen YY; Lin CC; Tsai CH; Kao CH Hepatogastroenterology; 2003; 50(54):2154-6. PubMed ID: 14696485 [TBL] [Abstract][Full Text] [Related]
12. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125 [TBL] [Abstract][Full Text] [Related]
13. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190 [TBL] [Abstract][Full Text] [Related]
14. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy. Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Iida Y; Higuchi T; Hanaoka H; Miyakubo M; Takano A; Ishikita T; Endo K Oncol Rep; 2007 Dec; 18(6):1469-73. PubMed ID: 17982632 [TBL] [Abstract][Full Text] [Related]
15. Hepatocelluar carcinoma in an accessory lobe of the liver revealed by 11C-acetate PET with a negative finding on FDG imaging. Huo L; Dang Y; Feng R; Zhuang H; Li F Clin Nucl Med; 2012 Apr; 37(4):393-5. PubMed ID: 22391716 [No Abstract] [Full Text] [Related]
17. 18F-FDG PET for hepatocellular carcinoma presenting with portal vein tumor thrombus. Hanajiri K; Mitsui H; Maruyama T; Kondo Y; Shiina S; Omata M; Nakagawa K J Gastroenterol; 2005 Oct; 40(10):1005-6. PubMed ID: 16261443 [No Abstract] [Full Text] [Related]
18. [FDG-PET in hepatocellular carcinoma. Based on one case]. Gil Martínez EM; Rabadán Bujalance F; Ponce Herrera C; Martínez Obrador D; Moya García F Rev Esp Med Nucl; 2004; 23(5):352-3. PubMed ID: 15450142 [TBL] [Abstract][Full Text] [Related]
19. [18F-Fluorodeoxyglucose uptake in hepatocellular carcinoma on positron emission tomography correlates with alpha-fetoprotein]. Shang JB; Li YH; Liu FY; Zeng QL; Wang JY; He XF; Chen Y Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):697-9. PubMed ID: 15201094 [TBL] [Abstract][Full Text] [Related]
20. Limited value of fluorine-18-fluorodeoxyglucose PET for the differential diagnosis of focal liver lesions in patients with chronic hepatitis C virus infection. Schröder O; Trojan J; Zeuzem S; Baum RP Nuklearmedizin; 1998; 37(8):279-85. PubMed ID: 9868710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]